4//SEC Filing
Simon, Christopher 4
Accession 0001127602-25-015052
CIK 0000313143other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 5:10 PM ET
Size
7.4 KB
Accession
0001127602-25-015052
Insider Transaction Report
Form 4
Simon, Christopher
DirectorPresident & CEO
Transactions
- Award
Common Stock
2025-05-16+21,405→ 335,112 total - Award
Non-qualified Stock Option (Right to Buy)
2025-05-16+46,342→ 46,342 totalExercise: $70.31Exp: 2032-05-16→ Common Stock (46,342 underlying)
Footnotes (4)
- [F1]The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
- [F3]This number includes unvested RSUs previously reported.
- [F4]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001674993
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 5:10 PM ET
- Size
- 7.4 KB